Austin, Texas – September 13, 2026 -- Findhelp has become the first specialty exchange to register with the Maryland Health Care Commission (MHCC), enabling social care referral and reporting support for the state's Rural Health Transformation Program (RHTP).

Vancouver – September 13, 2026 -- Century Lithium Corp. has submitted its Mine Plan of Operations and Nevada Reclamation Permit Application for the 100%-owned Angel Island lithium project in Esmeralda County, Nevada, starting the federal environmental review clock on one of the largest known sedimentary lithium deposits in the United States.

Ramat Gan, Israel – September 13, 2026 -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) will rebrand as Eocene Ltd. and begin trading under the ticker EOCN on the Nasdaq Capital Market starting September 10, 2026, after terminating its $20 million standby equity purchase agreement with Yorkville and regaining compliance with Nasdaq's minimum bid price rule.

Berlin – September 13, 2026 -- Four of Germany's leading scientific and health organizations have issued a joint call for a cross-departmental national prevention strategy, warning that roughly 40 percent of new cancer cases remain preventable despite decades of research.

Toronto – September 13, 2026 -- Canada Nickel Company Inc. (TSXV: CNC) (OTCQB: CNIKF) has filed independent NI 43-101 technical reports on SEDAR+ supporting the initial mineral resource estimate for its Nesbitt Nickel Sulphide Project and an updated estimate for the Deloro Nickel Sulphide Project, both located near Timmins, Ontario and 100% owned by the company.

Dublin – – September 13, 2026 -- LUMA Vision has secured an expanded FDA clearance for VERAFEYE, its procedural intelligence platform for minimally invasive cardiac procedures, moving the company closer to a planned commercial launch in early 2027.

Toronto – – September 13, 2026 -- Denarius Metals Corp. (Cboe CA: DMET; OTCQX: DNRSF) has secured a preferential option from the Regional Government of Castilla and Leon to acquire up to 28 new mining grids covering approximately 800 hectares adjacent to its Toral Project in Spain, a move that would expand its total land position in the Leon Mining District to roughly 3,700 hectares.

Vancouver – September 13, 2026 -- OceanaGold Corporation (TSX: OGC, NYSE: OGC) has lodged an application under New Zealand's Fast-track Approvals Act 2024 to extend the operating life of its Macraes gold mine from the current 2032 reserve horizon into the late 2030s.

Dallas – September 13, 2026 -- The U.S. Food and Drug Administration has accepted and filed the Biologics License Application for MOGENRY, an optogenetic gene therapy from Nanoscope Therapeutics designed to restore vision in retinitis pigmentosa patients with severe vision loss. If approved, MOGENRY would become the first gene-agnostic treatment available for this patient population, which currently has no approved therapy.

Taipei – September 12, 2026 -- HanchorBio Inc. (TWSE: 7827) said the U.S. Food and Drug Administration has cleared its HCB101 Single-Patient Expanded Access Protocol (HCB101-EA-001) as "safe to proceed," allowing a Phase 1 patient who showed clinical benefit to continue receiving the investigational drug beyond the parent trial.